<DOC>
	<DOCNO>NCT03036085</DOCNO>
	<brief_summary>The aim study compare effectiveness postoperative outcome liposomal bupivacaine v plain bupivacaine follow video-assisted thoracoscopic surgery . The investigator ' hypothesis liposomal bupivacaine decrease postoperative pain associate favorable postoperative outcome compare plain bupivacaine follow video-assisted thoracoscopic surgery .</brief_summary>
	<brief_title>Liposomal Bupivacaine Pain Control Following Thoracic Surgery .</brief_title>
	<detailed_description>Pain management remain primary concern many patient follow thoracic surgery . Suboptimal analgesia lead numerous postoperative complication like reduced cardiac , respiratory gastrointestinal function , septic thromboembolic complication , increase incidence develop chronic pain state , increase mortality high-risk patient multiple comorbidities , many others . Opioids distinct role postoperative analgesia . Although opioids positively affect surgery decade , associate number potentially severe side effect include prolonged ileus , nausea , vomit , central nervous system respiratory depression , development hyperalgesia , risk dependency abuse . These adverse effect increase overall cost treatment patient potentially result long hospital stay . Local infiltration regional block local anesthetic increasingly utilized thoracic surgery procedure alternative epidural analgesia . Bupivacaine widely use intercostal nerve block utility limit short duration action ( &lt; 6 hour ) . Perineural catheter continuous infusion bupivacaine use overcome limitation need expensive pump risk significant complication associate use catheter ( i.e . infection , septicemia , intravascular migration etc ) limit use . Encapsulation local anesthetic liposome novel method extends drug delivery . The use multivesicular liposome show provide slow steady release local anesthetic several day nonvascular administration . Liposomal bupivacaine novel formulary bupivacaine , design single-dose local infiltration surgical site produce postsurgical analgesia 72-96 hour . Liposomal bupivacaine currently license U.S. Food Drug Administration peripheral nerve block approve single-dose infiltration surgical site . However , show two retrospective study patient open thoracotomy lung , pleural mediastinal pathology liposomal bupivacaine intercostal nerve blockade associate increase pain control decrease length hospital stay compare thoracic epidural analgesia . This single-blind randomized prospective research study compare pain control postoperative outcome follow intercostal neural blockade liposomal bupivacaine versus plain bupivacaine plus epinephrine video-assisted thoracoscopic surgical procedure . Eligible patient would patient age old 18 year undergo video-assisted thoracoscopic lung resection Massachusetts General Hospital . Pregnant woman , prisoner , emergent case , patient 18 year , patient chronic pain , document alcohol drug abuse allergy bupivacaine exclude study . Primary end point self-reported pain score visual analog scale 0 10 postoperative day # 1 . By utilize mean difference self-reported pain score 1 point standard deviation 2.5 point , sample size 100 patient per group would need power ( beta ) 0.8 probability level ( alpha ) 0.05 . All patient would enrol Massachusetts General Hospital . The video-assisted thoracoscopic surgery intercostal nerve blockade plain bupivacaine plus epinephrine liposomal bupivacaine perform thoracic surgeon Massachusetts General Hospital . In operating room induction general anesthesia patient position lateral decubitus position , prepare drape sterile fashion . Under thoracoscopic guidance , posterior intercostal nerve block perform liposomal bupivacaine ( 13.3 mg/ml ) 0.5 % bupivacaine 1 % epinephrine . In liposomal bupivacaine group , total dose 266 mg liposomal bupivacaine ( one 20 ml vial 13.3 mg/ml ) per patient dilute total volume 40 ml use 20 ml normal saline . In bupivacaine group 20 ml 0.5 % bupivacaine 1 % epinephrine dilute total volume 40 ml use 20 ml normal saline . From 40 ml , 30 ml use posterior intercostal nerve block 10 ml inject locally surgical wound . If immediate postoperative pain score rat 4/10 great , intravenous patient control analgesia device provide hydromorphone 0.2 mg every 10 minute nonopioid analgesic need . No narcotic give spinal space . Oral metoclopramide ondansetron give need combat side effect narcotic .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Thoracic Diseases</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Eligible patient would patient age old 18 year undergo videoassisted thoracoscopic lung resection Massachusetts General Hospital . Pregnant woman , prisoner , emergent case , patient 18 year , patient chronic pain , document alcohol drug abuse allergy bupivacaine exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>postoperative pain</keyword>
	<keyword>video-assisted thoracoscopic surgery ( VATS )</keyword>
	<keyword>opioids</keyword>
	<keyword>bupivacaine</keyword>
	<keyword>liposomal bupivacaine</keyword>
	<keyword>analgesia</keyword>
	<keyword>local anesthetic</keyword>
</DOC>